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Introduction
Cardiovascular magnetic resonance (CMR) is a develop-
ing field with enormous potential because of its major at-
tributes of high image quality and resolution combined
with non-ionising radiation and versatility. With recent
major technological advances, there have been great im-
provements in acquisition speed and quality that makes
the use of CMR in a wide range of cardiac conditions ro-
bust and valuable. This article reviews the fundamentals
of CMR and its current clinical applications.
Fundamentals of Cardiovascular Magnetic Resonance
There are essentially three types of imaging sequence
that are used in the cardiovascular system: In spin-echo
imaging, the blood appears black and good-quality
anatomical imaging is obtained. In gradient-echo imag-
ing, the blood is white and the high-quality cine imaging
is used to identify regional myocardial function and ab-
normal flow patterns. The gradient-echo technique of ve-
locity mapping uses the phase of the MR signal to mea-
sure velocity; it usually behaves like 2-dimensional
Doppler, but unlike Doppler it can measure flow direct-
ly and can be extended into seven dimensions for com-
plex flow-dynamics problems [1]. CMR therefore con-
sists of applications of these sequences and their vari-
ants, which allows determination of cardiac physiology,
anatomy, metabolism, tissue characterisation, and vascu-
lar angiography.
For dedicated CMR, the environment typically incor-
porates medical gases, full invasive and non-invasive
physiological monitoring telemetry, stress infusion
pumps for adenosine and dobutamine, a power injector
for contrast studies, and full resuscitation equipment and
drugs. Experience has demonstrated that acutely ill and
anaesthetised patients can be safely managed within the
magnet in experienced centres. Modern CMR scanners
incorporate ultrafast technology that allows real-time
imaging (up to 50 frames per second), and ultrafast ap-
plications for assessing coronary artery disease (CAD).
Currently, most scans are still gated to the electrocardio-
gram, and in some cases also to the respiratory cycle us-
ing advanced diaphragm-monitoring techniques.
CMR is as safe as echocardiography. It is also safe for
scanning all prosthetic heart valves and for patients with
sternal wires, joint replacements, and retained epicardial
pacing leads. There is abundant evidence that stents are
safe to scan any time after insertion [2]. Pacemakers are
problematic. Although recent MR experience is encour-
aging, this should only be considered in centres of spe-
cialist experience. Other implantable electronic devices,
including defibrillators and cerebrovascular aneurysm
clips, are currently a contraindication to CMR.
Claustrophobia occurs in about 4% of patients but such
patients frequently respond to low-dose diazepam.
Established Clinical Indications
Aorta
The aorta is well-imaged by CMR over its entire length.
Three-point plane definition techniques are useful for
imaging in the long axis of the aorta with reference to
points in the ascending and descending limbs and the
arch. The ‘candy cane’ view shows the extent of dissec-
tions and the location of coarctation. Closer interrogation
of specific regions can also be made with orthogonal
planes. CMR has been shown to be more accurate than
transoesophageal echocardiography (TE) and computed
tomography (CT) in evaluating acute dissection [3], al-
though TE is often simpler to organise. CMR is ideal for
the long-term follow-up of these patients in order to ex-
clude aneurysm formation and other complications. In
coarctation, Doppler is often problematic, and CMR is
ideal in answering clinical issues, as well as being cost-
effective [4]. In addition, CMR can demonstrate the net
flow in collaterals as an index of stenosis severity.
Congenital Heart Disease
Echocardiography is ideal for monitoring congenital dis-
ease in the young, but with growth into adulthood and af-
ter corrective surgery, CMR plays a larger role and is of-
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ten complementary to TE. TE is better at defining fine
structure, such as valve morphology, whereas CMR is su-
perior for flow, conduits and great-vessel anatomy [5]. In
centres with expertise in both techniques, invasive
catheterisation is reserved mainly for pressure measure-
ments.
Angiography
For non-coronary angiography, CMR has become the in-
vestigation of choice. MR angiography (MRA) is fast,
non-invasive, simple and safe, requiring only a peripher-
al intravenous injection of gadolinium, and 4-20 s of 3D
acquisition on modern scanners. The data can be dis-
played in a rotating cine, which can, on the latest scan-
ners, be time-resolved (4D angiography). This has
proved useful for visualising the pulmonary arteries.
Major applications have been shown for the aorta, renal
and leg arteries [6], but the technique is not limited to
these areas. Recently, thrombus imaging with CMR in
the venous system has been demonstrated [7], and com-
parisons with established techniques for detection of
deep-vein thrombosis and pulmonary embolism are un-
der way.
Masses and Tumours
CMR defines the size, extent and relation of cardiac
masses to surrounding tissues [8]; in addition, tissue
characterisation and enhancement with gadolinium
yield valuable information. T1- and T2-weighted images
vary between masses according to their biochemical
composition; for example, pericardial cysts have a char-
acteristic high signal on T2 imaging, and the fat content
of tumours can be selectively ascertained using fat sup-
pression. Gadolinium enhancement reflects tumour vas-
cularity; therefore, positive enhancement typically oc-
curs in malignancy, although this is not excusive as vas-
cular benign tumours such as myxoma and haeman-
gioma also enhance. These additional characterisation
features are very useful clinically in the guidance of di-
agnosis and surgery. 
Assessment of Cardiac Volumes, Mass and Function
Ventricular function, volumes and mass are important
prognostic indicators in CAD and other cardiac disease.
Current clinical techniques (echocardiography, radionu-
clide ventriculography) have now been shown to be less
accurate and reproducible than CMR [9], which has be-
come the new gold standard. The interstudy reproducibil-
ity of CMR has been recognised by the pharmaceutical
industry, which is using CMR for drug development stud-
ies in order to reduce the sample size [10], which reduces
costs significantly. Comparisons of the current clinical
techniques with CMR show that mean values in popula-
tion vary between techniques by small amounts, but that
individual variation can be very substantial [11]. If indi-
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vidual patient clinical decisions are based on numerical
thresholds, then CMR is the preferred technique. The ac-
quisition of these parameters by CMR is now achievable
in a few minutes, and analysis techniques can also be
completed quickly.
Flow and Shunts
CMR is useful for the measurement of flow in the heart
and great vessels. The signal phase can be encoded for
velocity and used to produce 2D velocity maps corre-
sponding with the anatomical images. By measuring the
area of a vessel and the mean velocity within the vessel,
absolute measurements of instantaneous flow can be de-
rived. When run in cine mode, flow curves are generated
in which the area under the curve represents true flow in
the vessel. This is very valuable in the non-invasive mea-
surement of the pulmonary to systemic flow ratio in car-
diac shunting and in a number of other clinical scenarios.
Valvular Heart Disease
Echo is excellent for investigating valvular disease, but
CMR has its particular uses. In valvular regurgitation,
echo may not easily determine the severity of the regur-
gitant flow. With CMR, the regurgitation can be mea-
sured directly using reverse-flow measurement in diastole
[10]. Extension to assessment of mitral regurgitation in-
volves the subtraction of aortic flow from true left-ven-
tricular stroke volume, measured using the multislice
technique. This approach is especially useful when
surgery is being considered and clinical and echo results
are not concordant, or there is doubt. For valvular steno-
sis, Doppler is very reliable for assessment and CMR is
required less often, but useful if echo assessment fails.
Experience suggests that CMR is a valuable alternative to
echocardiography when flow across the valve is very ec-
centrically orientated.
Pericardium
The pericardial thickness is a guide to the presence of
constriction and can be measured using CMR. The thick-
ness is slightly greater than that measured with patholog-
ical studies due to chemical-shift artefact, caused by fat
overlying the thin fibrous pericardial tissue. The normal
CMR thickness of pericardium is therefore quoted as <4
mm. The pericardium appears black on CMR because of
its low water content, although in acute inflammation it
can enhance with gadolinium and appear bright. The
thickness of the pericardium needs to be distinguished
from any pericardial effusion. Pericardial effusion is
commonly black on spin-echo images, but bright on gra-
dient-echo cines, and this is a useful means of differenti-
ation. Pericardial calcification is not well-seen by CMR,
as calcium appears black, and therefore may simply ap-
pear as a localised area of pericardial thickening. CT is
the best technique for showing calcium. 
D. Pennell
149_153_Pennell  28-02-2007  07:37  Pagina 150
Cardiomyopathy
CMR is very useful in the assessment of cardiomyopathy
such as arrhythmogenic right ventricular cardiomyopathy
(ARVC), thalassaemia and dilated/hypertrophic cardiomy-
opathy. ARVC, which typically affects young men, causes
right ventricular tachycardia and sudden death. It is fa-
milial and many gene abnormalities of the cellular desmo-
some have been discovered, which reveals the disease to
be one of impaired intercellular integrity. Fibrofatty re-
placement occurs on the basis of injury and repair. The
disease presents with abnormalities of the right ventricle
(15% also have left ventricular involvement). These are
best delineated by CMR, as they can be subtle and lo-
calised [12]. The late stages, with a large poorly function-
ing right ventricular and widespread fat infiltration, is
readily identified, but the early stages, characterised by
discrete areas of fat infiltration, regional hypokinesia, lo-
calised myocardial thinning and abnormal trabeculations
pose a greater challenge, and CMR appears to be the best
technique. Experience is required to differentiate these
findings from normal variants. In particular, the normal
patterns of epicardial fat distribution associated with the
coronary arteries must be understood.
The assessment of myocardial iron overload has been
problematic in clinical practice, but recently a T2* CMR
technique has been established that allows reproducible
quantification of the iron concentration [13]. Results
show that iron loading in the myocardium is not correlat-
ed with that in other tissues, such as the blood and liver,
and must be examined separately. T2* values <20 ms in-
dicate iron overload, and nearly all cases of heart failure
(the commonest cause of death in these patients) occur
when the myocardial T2* is <10 ms. The technique has
shown that removing cardiac iron is best achieved using
oral chelators. T2* CMR combined with targeted chela-
tion has considerably reduced the premature mortality
from heart failure in thalassaemia.
In dilated cardiomyopathy, CMR has shown intramur-
al mid-wall striae of fibrosis in one-third of patients, and
no fibrosis in about half. These findings are very useful
for distinguishing dilated cardiomyopathy from heart
failure due to coronary artery disease. Recently, the pres-
ence and extent of late gadolinium enhancement has been
shown to predict outcome in dilated cardiomyopathy.
Hypertrophic cardiomyopathy can usually be diag-
nosed by echocardiography, but there are circumstances
when CMR is very useful. If the condition is suspected
but not confirmed by echo, CMR is ideal as a second-line
investigation. CMR also shows the distribution of hyper-
trophy, especially in isolated basal and apical hypertro-
phy, and is superior for quantification of myocardial
mass. Late gadolinium enhancement occurs in hyper-
trophic cardiomyopathy and is associated with a worse
prognosis. Finally, CMR is valuable for the assessment of
septal ablation techniques in locating the size and extent
of infarction and assessing rest and stress outflow tract
gradients.
Coronary Anomalies
Coronary anomalies occur in approximately 1% of the
population and are usually clinically silent. Their impor-
tance lies in the occurrence of sudden death in patients
who have a coronary artery passing between the great
vessels (aorta and pulmonary artery). This may occur be-
cause of compression or kinking during exercise. X-ray
coronary angiography commonly identifies the anom-
alous origin of the coronary artery, but is poor at defin-
ing the proximal course and the relation to the great ves-
sels. Coronary CMR is now a robust technique for show-
ing the origin and course of the proximal coronaries and
also the three-dimensional relations of the great vessels.
Several studies have shown that CMR is superior to X-
ray angiography for this purpose. More recently, coronary
CMR has been applied to evaluate patients with congen-
ital heart disease, in whom the incidence of coronary
anomaly is up to 30%. Defining the course by X-ray an-
giography is even more complex due to altered positions
of the great vessels and ventricles [14].
Developing Indications
Detection of Myocardial Infarction
The technique of late enhancement with gadolinium has
been developed, in which the heart is imaged 10-15 min
after injection. The gadolinium concentrates in the
necrotic (acute infarction) or scar tissue (chronic in-
farction) due to an increased partition coefficient, and
the infarcted area becomes bright [15]. There is very
close correlation of the volume of signal enhancement
and infarct size in animal models of acute infarction.
The technique has high resolution and can define the
transmural extent of necrosis and scar. In addition, a dif-
ferent technique, known as early enhancement (at 1-2
min after gadolinium injection) can be used to define
the extent of microvascular obstruction in infarctions.
Microvascular obstruction has already been shown to
predict remodelling and adverse cardiac events after in-
farction.
Assessment of Myocardial Viability
The technique of late enhancement has clinical applica-
tion to the assessment of viability in that the percentage
transmural replacement of normal myocardium by scar
can thus be determined. Segments with <50% trans-
mural replacement showed improved function with
revascularisation, whilst those with higher grades of
transmural replacement fail to improve [16]. It is antic-
ipated that the late enhancement technique will make
substantial clinical impact in the management of infarc-
tion and its sequelae.
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Dobutamine stress testing
Dobutamine CMR was first used for the detection of is-
chaemia in CAD a decade ago, but modern comparisons
with stress echocardiography have shown significantly
improved diagnosis related to improved results from
those patients in whom echocardiographic image quality
was suboptimal or poor [17]. Results from several centres
have begun to establish this technique, and where avail-
able, it can be considered as a first-line approach if
acoustic windows are limited.
CMR Techniques in Development
Myocardial Perfusion
SPECT is a widely used technique to assess perfusion, but
a safer technique would be medically welcome, providing
it can maintain the same valuable diagnostic and prognos-
tic information and is cost effective. Perfusion CMR may
be a contender for this role. This technique consists of a
baseline first-pass perfusion study and a repeat study dur-
ing adenosine stress. Gadolinium is used as the contrast
agent. Areas of reduced perfusion appear as dark areas in
the myocardium surrounded by normal-enhancing areas.
One of the advantages of perfusion CMR is high resolu-
tion, which allows the visualisation of subendocardial per-
fusion defects in vivo for the first time. Quantitative
analysis tools have been developed that examine the slope
of signal increase during the first pass and the myocardial
perfusion reserve index [18]. Other advantages of perfu-
sion CMR include the speed of the examination (1 h com-
pared with typically 2-6 h for a nuclear examination), and
the easy combination with other techniques, such as late
enhancement. Recent multicentre studies suggested that
CMR is more accurate than myocardial perfusion SPECT
for detection of coronary artery disease.
Atherosclerotic Plaque
Further down the road for clinical use is the technique of
plaque imaging. CMR can be used to depict plaques and
interrogate their lipid constituents as well as the integrity
of the fibrous cap, which are factors that determine the
propensity to plaque rupture and thrombus formation. T2
imaging has proved so far to be the most helpful, and val-
idation of results against pathology has been achieved in
the aorta and carotids. Latest results have also shown
plaques in the coronary arteries [19].
Coronary Imaging
Much work has been devoted to the non-invasive assess-
ment of the coronary artery lumen by CMR. There have
been tremendous improvements in techniques, notably in
the development of ‘navigators’ which allow patients to
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breathe freely during the acquisition, whilst increasing
resolution [20]. Most recently, 3D breath-hold techniques
during contrast-agent infusion have shown good results. It
is likely that coronary CMR will prove useful in CAD at
some point in the future, but currently its clinical robust-
ness needs improvement, and the issue of preventing coro-
nary motion during the acquisition has to be improved fur-
ther. However, the success of the technique for coronary
anomalies is established and vein-graft imaging by CMR
is now straightforward. In this area, coronary CT has ad-
vantage because of superior resolution, although in estab-
lished coronary disease, interpretation is considerably hin-
dered by coronary calcium. CT is good for detecting ear-
ly coronary disease, prior to excessive calcium deposition.
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